
The company said it had submitted a detailed compliance report to the US Food and Drug Administration (USFDA) within the stipulated period in response to the Form 483 containing eight observations issued to it by the regulator.
from Moneycontrol Business News https://ift.tt/2DeGRX9
No comments:
Post a Comment